CAREER HIGHLIGHTS: MAKING BIOTECHNOLOGY WORK FOR THE PUBLIC GOOD
Advanced numerous infectious disease diagnostic testing programs and public health interventions to reduce the burden of disease and risks from environmental threats, as well as synthetic biology programs and several first-in-class genetically engineered commercial products.
Advanced numerous infectious disease diagnostic testing programs and public health interventions to reduce the burden of disease and risks from environmental threats, as well as synthetic biology programs and several first-in-class genetically engineered commercial products.
TECHNOLOGY STRATEGY
TECHNOLOGY STRATEGY
TECHNOLOGY STRATEGY
  • Led internal, external, and open innovation functions to advance new product development and collaborations for large publicly traded multi-national biotechnology company (Intrexon)
  • Marketed and advanced several FDA, USDA, and EPA regulated first-in-class gene-edited and genetically engineered (GE) organisms for food, environmental, and public health applications (GE fish, GE fruit, GE insects, GE microbes), as well as animal cloning technologies (Intrexon)
  • Performed technology analysis, technical diligence, and post-acquisition integration to support biotechnology acquisitions exceeding $400M (Intrexon) (see list)
  • Led internal, external, and open innovation functions to advance new product development and collaborations for large publicly traded multi-national biotechnology company (Intrexon)
  • Marketed and advanced several FDA, USDA, and EPA regulated first-in-class gene-edited and genetically engineered (GE) organisms for food, environmental, and public health applications (GE fish, GE fruit, GE insects, GE microbes), as well as animal cloning technologies (Intrexon)
  • Performed technology analysis, technical diligence, and post-acquisition integration to support biotechnology acquisitions exceeding $400M (Intrexon) (see list)
  • Led internal, external, and open innovation functions to advance new product development and collaborations for large publicly traded multi-national biotechnology company (Intrexon)
  • Marketed and advanced several FDA, USDA, and EPA regulated first-in-class gene-edited and genetically engineered (GE) organisms for food, environmental, and public health applications (GE fish, GE fruit, GE insects, GE microbes), as well as animal cloning technologies (Intrexon)
  • Performed technology analysis, technical diligence, and post-acquisition integration to support biotechnology acquisitions exceeding $400M (Intrexon) (see list)
BIOTECHNOLOGY DEVELOPMENT
BIOTECHNOLOGY DEVELOPMENT
BIOTECHNOLOGY DEVELOPMENT
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
  • Advanced multiple biotechnology new product development programs and initiatives (see list)
  • Specialized experience developing FDA regulated medical diagnostics (see list)
PUBLIC HEALTH INNOVATION
PUBLIC HEALTH INNOVATION
PUBLIC HEALTH INNOVATION
  • Supported protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Supported protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Supported protocol design and deployment of pioneering HIV/CD4 mobile testing in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital Malawi)
  • Developed biotechnologies with public health applications:
  • Developed biotechnologies with public health applications:
  • Developed biotechnologies with public health applications:
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Chronic disease diagnostic technologies for genetic screening and cancer biomarker profiling (Exonhit, Intrexon)
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Chronic disease diagnostic technologies for genetic screening and cancer biomarker profiling (Exonhit, Intrexon)
  • Compact dual-use integrated immunoassay and molecular testing platform for infectious disease diagnostics and biothreat detection (Vectrant)
  • Chronic disease diagnostic technologies for genetic screening and cancer biomarker profiling (Exonhit, Intrexon)
  • Marketed biotechnologies with environmental and public health applications:
  • Marketed biotechnologies with environmental and public health applications:
  • Marketed biotechnologies with environmental and public health applications:
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)
  • Viral-based vaccines for disease prevention and biodefense countermeasures (Intrexon)
  • Genetically engineered salmon using more sustainable terrestrial aquaculture to reduce impacts on wild fisheries and the environment (Intrexon)
  • Animal cloning of elite genetics to improve food systems and accessibility to quality protein and milk (Intrexon)
Return to MY WORK
Return to MY WORK